APO Research
Talk to an analyst

APO RESEARCH · REPORT

OTC Painkillers

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global OTC Painkillers Market Outlook and Growth Opportunities 2026

20 December 2025190 pages

Choose your research edition.

Industry ResearchOTC Painkillers Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal OTC Painkillers Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal OTC Painkillers Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal OTC Painkillers Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal OTC Painkillers Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global OTC Painkillers market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for OTC Painkillers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for OTC Painkillers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for OTC Painkillers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the OTC Painkillers market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the OTC Painkillers market include Genetic Pharmaceuticals, Sanofi, Johnson & Johnson, Novartis, Prestige Brands, Pfizer, GSK, Dupont Pharmaceuticals and Bausch + Lomb, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global OTC Painkillers market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of OTC Painkillers and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents OTC Painkillers revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global OTC Painkillers market.

OTC Painkillers Segment by Company

Genetic Pharmaceuticals

Sanofi

Johnson & Johnson

Novartis

Prestige Brands

Pfizer

GSK

Dupont Pharmaceuticals

Bausch + Lomb

Bayer

AstraZeneca

Alvogen

Westwood-Squibb Pharmaceuticals

Reckitt Benckiser

Morton Pharmaceuticals

OTC Painkillers Segment by Type

NSAIDs

Acetaminophen

Others

OTC Painkillers Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

OTC Painkillers Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global OTC Painkillers status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the OTC Painkillers key companies, revenue, market share, and recent developments.

3. To split the OTC Painkillers breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions OTC Painkillers market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify OTC Painkillers significant trends, drivers, influence factors in global and regions.

6. To analyze OTC Painkillers competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Painkillers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of OTC Painkillers and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Painkillers.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global OTC Painkillers industry.

Chapter 3: Detailed analysis of OTC Painkillers company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of OTC Painkillers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of OTC Painkillers in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. OTC Painkillers Industry Trends Table 2. OTC Painkillers Industry Drivers Table 3. OTC Painkillers Industry Opportunities and Challenges Table 4. OTC Painkillers Industry Restraints Table 5. Global OTC Painkillers Revenue by Company (US$ Million) & (2021-2026) Table 6. Global OTC Painkillers Revenue Share by Company (2021-2026) Table 7. Global OTC Painkillers Company Ranking, (2024-2026) & (US$ Million) Table 8. Global OTC Painkillers Key Company Manufacturing Base & Headquarters Table 9. Global OTC Painkillers Company, Product Type & Application Table 10. Global OTC Painkillers Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global OTC Painkillers by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of NSAIDs Table 15. Significant Companies of Acetaminophen Table 16. Significant Companies of Others Table 17. Global OTC Painkillers Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global OTC Painkillers Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global OTC Painkillers Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global OTC Painkillers Sales Value Share by Type (2021-2026) Table 21. Global OTC Painkillers Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Hospital Pharmacies Table 23. Significant Companies of Online Pharmacies Table 24. Significant Companies of Retail Pharmacies Table 25. Global OTC Painkillers Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global OTC Painkillers Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global OTC Painkillers Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global OTC Painkillers Sales Value Share by Application (2021-2026) Table 29. Global OTC Painkillers Sales Value Share by Application (2027-2032) Table 30. Global OTC Painkillers Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global OTC Painkillers Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global OTC Painkillers Sales Value Share by Region (2021-2026) Table 33. Global OTC Painkillers Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global OTC Painkillers Sales Value Share by Region (2027-2032) Table 35. Global OTC Painkillers Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global OTC Painkillers Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global OTC Painkillers Sales Value Market Share by Country (2021-2026) Table 38. Global OTC Painkillers Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global OTC Painkillers Sales Value Market Share by Country (2027-2032) Table 40. Genetic Pharmaceuticals Company Information Table 41. Genetic Pharmaceuticals Business Overview Table 42. Genetic Pharmaceuticals OTC Painkillers Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Genetic Pharmaceuticals OTC Painkillers Product Portfolio Table 44. Genetic Pharmaceuticals Recent Development Table 45. Sanofi Company Information Table 46. Sanofi Business Overview Table 47. Sanofi OTC Painkillers Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Sanofi OTC Painkillers Product Portfolio Table 49. Sanofi Recent Development Table 50. Johnson & Johnson Company Information Table 51. Johnson & Johnson Business Overview Table 52. Johnson & Johnson OTC Painkillers Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Johnson & Johnson OTC Painkillers Product Portfolio Table 54. Johnson & Johnson Recent Development Table 55. Novartis Company Information Table 56. Novartis Business Overview Table 57. Novartis OTC Painkillers Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Novartis OTC Painkillers Product Portfolio Table 59. Novartis Recent Development Table 60. Prestige Brands Company Information Table 61. Prestige Brands Business Overview Table 62. Prestige Brands OTC Painkillers Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Prestige Brands OTC Painkillers Product Portfolio Table 64. Prestige Brands Recent Development Table 65. Pfizer Company Information Table 66. Pfizer Business Overview Table 67. Pfizer OTC Painkillers Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Pfizer OTC Painkillers Product Portfolio Table 69. Pfizer Recent Development Table 70. GSK Company Information Table 71. GSK Business Overview Table 72. GSK OTC Painkillers Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. GSK OTC Painkillers Product Portfolio Table 74. GSK Recent Development Table 75. Dupont Pharmaceuticals Company Information Table 76. Dupont Pharmaceuticals Business Overview Table 77. Dupont Pharmaceuticals OTC Painkillers Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Dupont Pharmaceuticals OTC Painkillers Product Portfolio Table 79. Dupont Pharmaceuticals Recent Development Table 80. Bausch + Lomb Company Information Table 81. Bausch + Lomb Business Overview Table 82. Bausch + Lomb OTC Painkillers Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Bausch + Lomb OTC Painkillers Product Portfolio Table 84. Bausch + Lomb Recent Development Table 85. Bayer Company Information Table 86. Bayer Business Overview Table 87. Bayer OTC Painkillers Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Bayer OTC Painkillers Product Portfolio Table 89. Bayer Recent Development Table 90. AstraZeneca Company Information Table 91. AstraZeneca Business Overview Table 92. AstraZeneca OTC Painkillers Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. AstraZeneca OTC Painkillers Product Portfolio Table 94. AstraZeneca Recent Development Table 95. Alvogen Company Information Table 96. Alvogen Business Overview Table 97. Alvogen OTC Painkillers Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Alvogen OTC Painkillers Product Portfolio Table 99. Alvogen Recent Development Table 100. Westwood-Squibb Pharmaceuticals Company Information Table 101. Westwood-Squibb Pharmaceuticals Business Overview Table 102. Westwood-Squibb Pharmaceuticals OTC Painkillers Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Westwood-Squibb Pharmaceuticals OTC Painkillers Product Portfolio Table 104. Westwood-Squibb Pharmaceuticals Recent Development Table 105. Reckitt Benckiser Company Information Table 106. Reckitt Benckiser Business Overview Table 107. Reckitt Benckiser OTC Painkillers Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Reckitt Benckiser OTC Painkillers Product Portfolio Table 109. Reckitt Benckiser Recent Development Table 110. Morton Pharmaceuticals Company Information Table 111. Morton Pharmaceuticals Business Overview Table 112. Morton Pharmaceuticals OTC Painkillers Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Morton Pharmaceuticals OTC Painkillers Product Portfolio Table 114. Morton Pharmaceuticals Recent Development Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. OTC Painkillers Product Image Figure 2. Global OTC Painkillers Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global OTC Painkillers Market Size (2021-2032) & (US$ Million) Figure 4. Global OTC Painkillers Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. NSAIDs Image Figure 8. Acetaminophen Image Figure 9. Others Image Figure 10. Global OTC Painkillers Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global OTC Painkillers Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global OTC Painkillers Sales Value Share by Type (2021-2032) Figure 13. Hospital Pharmacies Image Figure 14. Online Pharmacies Image Figure 15. Retail Pharmacies Image Figure 16. Global OTC Painkillers Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global OTC Painkillers Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global OTC Painkillers Sales Value Share by Application (2021-2032) Figure 19. Global OTC Painkillers Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global OTC Painkillers Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America OTC Painkillers Sales Value (2021-2032) & (US$ Million) Figure 22. North America OTC Painkillers Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe OTC Painkillers Sales Value (2021-2032) & (US$ Million) Figure 24. Europe OTC Painkillers Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific OTC Painkillers Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific OTC Painkillers Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America OTC Painkillers Sales Value (2021-2032) & (US$ Million) Figure 28. South America OTC Painkillers Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa OTC Painkillers Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa OTC Painkillers Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA OTC Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA OTC Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA OTC Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada OTC Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada OTC Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada OTC Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico OTC Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico OTC Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico OTC Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany OTC Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany OTC Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany OTC Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France OTC Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France OTC Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France OTC Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. OTC Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. OTC Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. OTC Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy OTC Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy OTC Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy OTC Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain OTC Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain OTC Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain OTC Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia OTC Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia OTC Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia OTC Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands OTC Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands OTC Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands OTC Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries OTC Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries OTC Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries OTC Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China OTC Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China OTC Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China OTC Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan OTC Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan OTC Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan OTC Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea OTC Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea OTC Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea OTC Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India OTC Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India OTC Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India OTC Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia OTC Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia OTC Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia OTC Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia OTC Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia OTC Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia OTC Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil OTC Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil OTC Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil OTC Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina OTC Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina OTC Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina OTC Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile OTC Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile OTC Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile OTC Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia OTC Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia OTC Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia OTC Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru OTC Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru OTC Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru OTC Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia OTC Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia OTC Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia OTC Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel OTC Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel OTC Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel OTC Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE OTC Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE OTC Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE OTC Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey OTC Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey OTC Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey OTC Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran OTC Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran OTC Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran OTC Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt OTC Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt OTC Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt OTC Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • NSAIDs
  • Acetaminophen
  • Others
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Genetic Pharmaceuticals
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Prestige Brands
  • Pfizer
  • GSK
  • Dupont Pharmaceuticals
  • Bausch + Lomb
  • Bayer
  • AstraZeneca
  • Alvogen
  • Westwood-Squibb Pharmaceuticals
  • Reckitt Benckiser
  • Morton Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global OTC Painkillers Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global OTC Painkillers Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 OTC Painkillers Market Dynamics
  1. 2.1 OTC Painkillers Industry Trends
  2. 2.2 OTC Painkillers Industry Drivers
  3. 2.3 OTC Painkillers Industry Opportunities and Challenges
  4. 2.4 OTC Painkillers Industry Restraints
3 OTC Painkillers Market by Company
  1. 3.1 Global OTC Painkillers Company Revenue Ranking in 2025
  2. 3.2 Global OTC Painkillers Revenue by Company (2021-2026)
  3. 3.3 Global OTC Painkillers Company Ranking (2024-2026)
  4. 3.4 Global OTC Painkillers Company Manufacturing Base and Headquarters
  5. 3.5 Global OTC Painkillers Company Product Type and Application
  6. 3.6 Global OTC Painkillers Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global OTC Painkillers Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 OTC Painkillers Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 OTC Painkillers Market by Type
  1. 4.1 OTC Painkillers Type Introduction
  2. 4.1.1 NSAIDs
  3. 4.1.2 Acetaminophen
  4. 4.1.3 Others
  5. 4.2 Global OTC Painkillers Sales Value by Type
  6. 4.2.1 Global OTC Painkillers Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global OTC Painkillers Sales Value by Type (2021-2032)
  8. 4.2.3 Global OTC Painkillers Sales Value Share by Type (2021-2032)
5 OTC Painkillers Market by Application
  1. 5.1 OTC Painkillers Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global OTC Painkillers Sales Value by Application
  6. 5.2.1 Global OTC Painkillers Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global OTC Painkillers Sales Value by Application (2021-2032)
  8. 5.2.3 Global OTC Painkillers Sales Value Share by Application (2021-2032)
6 OTC Painkillers Regional Value Analysis
  1. 6.1 Global OTC Painkillers Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global OTC Painkillers Sales Value by Region (2021-2032)
  3. 6.2.1 Global OTC Painkillers Sales Value by Region: 2021-2026
  4. 6.2.2 Global OTC Painkillers Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America OTC Painkillers Sales Value (2021-2032)
  7. 6.3.2 North America OTC Painkillers Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe OTC Painkillers Sales Value (2021-2032)
  10. 6.4.2 Europe OTC Painkillers Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific OTC Painkillers Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific OTC Painkillers Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America OTC Painkillers Sales Value (2021-2032)
  16. 6.6.2 South America OTC Painkillers Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa OTC Painkillers Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa OTC Painkillers Sales Value Share by Country, 2025 VS 2032
7 OTC Painkillers Country-level Value Analysis
  1. 7.1 Global OTC Painkillers Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global OTC Painkillers Sales Value by Country (2021-2032)
  3. 7.2.1 Global OTC Painkillers Sales Value by Country (2021-2026)
  4. 7.2.2 Global OTC Painkillers Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA OTC Painkillers Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA OTC Painkillers Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA OTC Painkillers Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada OTC Painkillers Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada OTC Painkillers Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada OTC Painkillers Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico OTC Painkillers Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico OTC Painkillers Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico OTC Painkillers Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany OTC Painkillers Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany OTC Painkillers Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany OTC Painkillers Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France OTC Painkillers Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France OTC Painkillers Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France OTC Painkillers Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. OTC Painkillers Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. OTC Painkillers Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. OTC Painkillers Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy OTC Painkillers Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy OTC Painkillers Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy OTC Painkillers Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain OTC Painkillers Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain OTC Painkillers Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain OTC Painkillers Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia OTC Painkillers Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia OTC Painkillers Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia OTC Painkillers Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands OTC Painkillers Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands OTC Painkillers Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands OTC Painkillers Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries OTC Painkillers Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries OTC Painkillers Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries OTC Painkillers Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China OTC Painkillers Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China OTC Painkillers Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China OTC Painkillers Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan OTC Painkillers Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan OTC Painkillers Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan OTC Painkillers Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea OTC Painkillers Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea OTC Painkillers Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea OTC Painkillers Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India OTC Painkillers Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India OTC Painkillers Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India OTC Painkillers Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia OTC Painkillers Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia OTC Painkillers Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia OTC Painkillers Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia OTC Painkillers Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia OTC Painkillers Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia OTC Painkillers Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil OTC Painkillers Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil OTC Painkillers Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil OTC Painkillers Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina OTC Painkillers Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina OTC Painkillers Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina OTC Painkillers Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile OTC Painkillers Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile OTC Painkillers Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile OTC Painkillers Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia OTC Painkillers Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia OTC Painkillers Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia OTC Painkillers Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru OTC Painkillers Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru OTC Painkillers Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru OTC Painkillers Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia OTC Painkillers Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia OTC Painkillers Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia OTC Painkillers Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel OTC Painkillers Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel OTC Painkillers Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel OTC Painkillers Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE OTC Painkillers Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE OTC Painkillers Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE OTC Painkillers Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey OTC Painkillers Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey OTC Painkillers Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey OTC Painkillers Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran OTC Painkillers Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran OTC Painkillers Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran OTC Painkillers Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt OTC Painkillers Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt OTC Painkillers Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt OTC Painkillers Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Genetic Pharmaceuticals
  2. 8.1.1 Genetic Pharmaceuticals Company Information
  3. 8.1.2 Genetic Pharmaceuticals Business Overview
  4. 8.1.3 Genetic Pharmaceuticals OTC Painkillers Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Genetic Pharmaceuticals OTC Painkillers Product Portfolio
  6. 8.1.5 Genetic Pharmaceuticals Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi OTC Painkillers Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi OTC Painkillers Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Johnson & Johnson
  14. 8.3.1 Johnson & Johnson Company Information
  15. 8.3.2 Johnson & Johnson Business Overview
  16. 8.3.3 Johnson & Johnson OTC Painkillers Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Johnson & Johnson OTC Painkillers Product Portfolio
  18. 8.3.5 Johnson & Johnson Recent Developments
  19. 8.4 Novartis
  20. 8.4.1 Novartis Company Information
  21. 8.4.2 Novartis Business Overview
  22. 8.4.3 Novartis OTC Painkillers Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Novartis OTC Painkillers Product Portfolio
  24. 8.4.5 Novartis Recent Developments
  25. 8.5 Prestige Brands
  26. 8.5.1 Prestige Brands Company Information
  27. 8.5.2 Prestige Brands Business Overview
  28. 8.5.3 Prestige Brands OTC Painkillers Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Prestige Brands OTC Painkillers Product Portfolio
  30. 8.5.5 Prestige Brands Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer OTC Painkillers Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer OTC Painkillers Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 GSK
  38. 8.7.1 GSK Company Information
  39. 8.7.2 GSK Business Overview
  40. 8.7.3 GSK OTC Painkillers Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GSK OTC Painkillers Product Portfolio
  42. 8.7.5 GSK Recent Developments
  43. 8.8 Dupont Pharmaceuticals
  44. 8.8.1 Dupont Pharmaceuticals Company Information
  45. 8.8.2 Dupont Pharmaceuticals Business Overview
  46. 8.8.3 Dupont Pharmaceuticals OTC Painkillers Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Dupont Pharmaceuticals OTC Painkillers Product Portfolio
  48. 8.8.5 Dupont Pharmaceuticals Recent Developments
  49. 8.9 Bausch + Lomb
  50. 8.9.1 Bausch + Lomb Company Information
  51. 8.9.2 Bausch + Lomb Business Overview
  52. 8.9.3 Bausch + Lomb OTC Painkillers Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Bausch + Lomb OTC Painkillers Product Portfolio
  54. 8.9.5 Bausch + Lomb Recent Developments
  55. 8.10 Bayer
  56. 8.10.1 Bayer Company Information
  57. 8.10.2 Bayer Business Overview
  58. 8.10.3 Bayer OTC Painkillers Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Bayer OTC Painkillers Product Portfolio
  60. 8.10.5 Bayer Recent Developments
  61. 8.11 AstraZeneca
  62. 8.11.1 AstraZeneca Company Information
  63. 8.11.2 AstraZeneca Business Overview
  64. 8.11.3 AstraZeneca OTC Painkillers Revenue and Gross Margin (2021-2026)
  65. 8.11.4 AstraZeneca OTC Painkillers Product Portfolio
  66. 8.11.5 AstraZeneca Recent Developments
  67. 8.12 Alvogen
  68. 8.12.1 Alvogen Company Information
  69. 8.12.2 Alvogen Business Overview
  70. 8.12.3 Alvogen OTC Painkillers Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Alvogen OTC Painkillers Product Portfolio
  72. 8.12.5 Alvogen Recent Developments
  73. 8.13 Westwood-Squibb Pharmaceuticals
  74. 8.13.1 Westwood-Squibb Pharmaceuticals Company Information
  75. 8.13.2 Westwood-Squibb Pharmaceuticals Business Overview
  76. 8.13.3 Westwood-Squibb Pharmaceuticals OTC Painkillers Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Westwood-Squibb Pharmaceuticals OTC Painkillers Product Portfolio
  78. 8.13.5 Westwood-Squibb Pharmaceuticals Recent Developments
  79. 8.14 Reckitt Benckiser
  80. 8.14.1 Reckitt Benckiser Company Information
  81. 8.14.2 Reckitt Benckiser Business Overview
  82. 8.14.3 Reckitt Benckiser OTC Painkillers Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Reckitt Benckiser OTC Painkillers Product Portfolio
  84. 8.14.5 Reckitt Benckiser Recent Developments
  85. 8.15 Morton Pharmaceuticals
  86. 8.15.1 Morton Pharmaceuticals Company Information
  87. 8.15.2 Morton Pharmaceuticals Business Overview
  88. 8.15.3 Morton Pharmaceuticals OTC Painkillers Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Morton Pharmaceuticals OTC Painkillers Product Portfolio
  90. 8.15.5 Morton Pharmaceuticals Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst